Causes We Are Currently Fighting
Thousands of drugs and devices go on the market every year that prove to be a danger to consumers. We are dedicated to providing those injured or ill with valuable information to help you understand what caused your adverse health affects and what your legal options are. A few of the causes we are currently fighting include injuries caused by drugs like Invokana®, Risperdal®, Bravelle® and Physiomesh®.
Who We Are
We are a Texas-based law firm dedicated to defective products and serious personal injury litigation for clients across the United States. Avram Blair & Associates, P.C. is passionate about helping individuals and families injured by defective products.
What We Do
We provide valuable information about dangerous drugs, medical devices, and catastrophic injuries to those who need it. We also provide a connection to the valuable legal team at Avram Blair & Associates, P.C., a law practice dedicated to helping individuals and families injured by defective products.
Why We Do It
We truly care about the welfare of people who suffered serious injury from defective products and dangerous drugs. Consumers deserve access to the right information so that they may understand the causes of their injuries or illness. At Avram Blair & Associates, P.C. we are dedicated to ensuring those who have been injured have assistance in navigating the information and the opportunity to proceed with legal recourse.
The Supreme Court of the United States passes approval for former NFL players to begin receiving payouts from a $1 billion settlement with the NFL in the class-action concussion lawsuit. This lawsuit was filed in 2011, when a group of retired NFL players filed claims...
The latest Risperdal® case against Johnson & Johnson Pharmaceuticals sets record jury-verdict of $70 million in a Philadelphia court to the plaintiff, Andrew Yount. The U.S Jury announced this verdict on July 1, 2016, the latest of Risperdal® lawsuits currently...
Janssen Pharmaceuticals, Inc. announced on September 21, 2016 that the U.S. Food and Drug Administration (FDA) approved Invokamet® XR, it’s latest medication for Type 2 Diabetes. Invokamet® XR is an addition to a new class of medications for Type 2 diabetes...